RRRicardo Ramírez-Barrantes

Ricardo Ramírez-Barrantes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ricardo Ramírez-Barrantes has a total of 58 co-authors. Here are the top co-authors by number of shared publications:

  • Claudio Córdova

    Facultad de Medicina, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile; Centro Interdisciplinario de Investigación Biomédica e Ingeniería para la Salud MEDING, Universidad de Valparaíso, Chile

    5 shared publications
  • Pablo Olivero

    Laboratorio de Estructura y Función Celular, Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile

    5 shared publications
  • Carlo Lozano

    Laboratorio de Estructura y Función Celular, Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Hontaneda 2664, 2341386 Valparaíso, Chile

    2 shared publications
  • Ivanny Marchant

    Laboratorio de Estructura y Función Celular, Escuela de Medicina, Facultad de Medicina, Universidad de Valparaíso, Valparaíso, Chile

    2 shared publications
  • Ivanny Marchant

    Laboratorio de Modelamiento en Medicina, Facultad de Medicina, Universidad de Valparaíso

    2 shared publications
  • Antonella Pereira

    Laboratory of Neuroeducation and Well-Being, Faculty of Medicine, Andrés Bello University

    1 shared publication

Latest Publications

  • Open Access

    Yoga-based meditation improves self-regulation and well-being in medical students: a pilot study

    by Felipe Rojas-Thomas, Ignacia Cantwell, Claudio Artigas, Diego Garrido, Jessica Goset, María Jose Olivares, Joaquín Araya, Benjamin Ibañez, Antonella Pereira, María Carolina Otero, et al.

    Introduction: Self-regulation enables students to effectively apply their metacognitive abilities to reach academic objectives and enhance their well-being, which is essential in academic high-pressure situations such as medical education. However, many medical students have difficulty managing their cognitive and emotional responses to continued academic pressure and the clinical demands placed upon them. Thus, it is important to identify methods that may support the self-regulatory abilities of medical students. Methods: This study assessed whether participation in a yoga-based meditation program was associated with pre-to-post changes in cognitive and psychological indicators of self-regulation among medical students. The sample consisted of forty subjects who completed a series of self-report questionnaires assessing anxiety, stress, depression (DASS-21 and STAI), mindfulness (FFMQ), and overall mental health or psychological well-being (WEMWBS). In addition to completing the self-report measures, each subject’s cognitive performance was measured before and after completion of the intervention program using three separate tasks: AOSPAN for working memory, a free recall task to measure episodic memory, and SART for sustained attention. Results: Pre/post assessments revealed statistically significant decreases in reported levels of anxiety, stress, and depression. Conversely, there were statistically significant increases in reported levels of psychological well-being and global mindfulness meta-awareness. Following the intervention, cognitive task performance also changed. Specifically, we observed significant increases in working memory performance, immediate and delayed episodic memory, and response accuracy, together with response-time dynamics consistent with a more cautious response pattern. Discussion: These results suggest that yoga-based meditation was associated with pre-to-post changes in cognitive and psychological indicators of self-regulation, although causal interpretation is limited by the single-group pilot design. Taken together, these findings support further investigation of meditation-based programs as low-cost and scalable approaches to support cognitive performance and overall well-being in demanding educational settings such as medical education.

  • Open Access

    Documentary Analysis of Hypericum perforatum (St. John’s Wort) and Its Effect on Depressive Disorders

    by María Carolina Otero, Francisco Ceric, Sebastián Miranda-Rojas, Carolina Carreño, Rachelly Escares, María José Escobar, Chiara Saracini, Cristian Atala, Ricardo Ramírez-Barrantes, Felipe Gordillo-Fuenzalida

    Hypericum perforatum, also known as St. John’s Wort, pericon, or yellow grass, is known for its antidepressant potential. It could represent a natural alternative to current pharmacological antidepressant treatments, which have a high incidence of side effects in patients and therefore lead to early dropouts. Through a bibliographic revision of clinical trials and information collected from scientific articles during the first period of 2020, we aimed to evaluate whether its administration could be beneficial in the treatment of mild-to-moderate depression, with fewer side effects compared to synthetic drugs. Among the main components, hypericin and hyperforin have been related to the observed antidepressant activity; therefore, their possible mechanism of action was reviewed and highlighted. Furthermore, patients receiving Hypericum extracts were less likely to withdraw from studies because of adverse effects compared to those receiving older standard antidepressants. This review aims to provide suggestions for an alternative treatment of mild-to-moderate depression disorder under the supervision of a medical doctor, since, although it appears to be a potentially efficient treatment with a low presence of adverse effects in comparison to synthetic antidepressants, it might also interact with other medications and lead to therapeutic failures if misused for self-medication.


  • Abstract 959: C/EBPβ antagonist peptide, ST101, as a therapeutic approach in breast cancer

    by Jim A. Rotolo, Mark Koester, Ricardo Ramirez, Lila Ghamsari, Siok Leong, Erin Gallagher, Gene Merutka, Barry J. Kappel

    Breast cancer (BC) is the most common invasive cancer in women, with more than 2.1 million cases and over 626,000 deaths occurring worldwide annually. Although age-adjusted mortality from BC has been declining since 1990, the median survival for patients with metastatic disease remains at 2-3 years, and 5-year survival approximates 25%. Thus, the medical need for more effective agents in this clinical setting remains very high. CCAAT/Enhancer Binding Protein Beta (C/EBPβ) is a transcription factor overexpressed in many cancers that regulates expression of factors that promote tumor survival, proliferation and inhibit differentiation. C/EBPβ dimers, such as with Jun/Fos and CREB/ATF family members, form via basic leucine zipper (bZIP)-driven coiled-coil interactions and are necessary for its association with DNA and transcriptional activity. Due in part to the difficulty in therapeutically targeting transcription factors, no effective C/EBPβ inhibitors are clinically available. ST101 is a novel peptide antagonist of C/EBPβ currently being evaluated in a Phase 1/2 clinical study in patients with advanced unresectable and metastatic solid tumors. ST101 was designed to bind the C/EBPβ bZIP domain, thereby preventing dimer formation and inhibiting its transcriptional activity. Here we describe ST101 non-clinical anti-tumor activity to support further development as a therapeutic approach in BC. In vitro studies in 4T1-luc triple-negative breast cancer (TNBC) and MCF7 HRPOS breast adenocarcinoma cells demonstrate ST101 dose-dependent impact of cell viability (EC50 of 4.8 and 2.1 µM, respectively), accompanied by significant impact on C/EBPβ-mediated gene expression as determined by qPCR analysis. In contrast, normal human mammary epithelial cells were not sensitive to ST101 (EC50 >100 µM). In vivo experiments indicate dose-dependent tumor growth inhibition in an orthotopic 4T1-luc model following ST101 exposure, with significant tumor growth delays observed following 25 mg/kg ST101 (pPOS and TN BC. Citation Format: Jim A. Rotolo, Mark Koester, Ricardo Ramirez, Lila Ghamsari, Siok Leong, Erin Gallagher, Gene Merutka, Barry J. Kappel. C/EBPβ antagonist peptide, ST101, as a therapeutic approach in breast cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 959.

  • Open Access

    Default Mode Network, Meditation, and Age-Associated Brain Changes: What Can We Learn from the Impact of Mental Training on Well-Being as a Psychotherapeutic Approach?

    by Ricardo Ramírez-Barrantes, Marcelo Arancibia, Jana Stojanova, Mauricio Aspé-Sánchez, Claudio Córdova, Rodrigo A. Henríquez-Ch

    Aging is a physiological process accompanied by cognitive decline, principally in memory and executive functions. Alterations in the connectivity of the default mode network (DMN) have been found to participate in cognitive decline, as well as in several neurocognitive disorders. The DMN has antisynchronic activity with attentional networks (task-positive networks (TPN)), which are critical to executive function and memory. Findings pointing to the regulation of the DMN via activation of TPN suggest that it can be used as a strategy for neuroprotection. Meditation is a noninvasive and nonpharmacological technique proven to increase meta-awareness, a cognitive ability which involves the control of both networks. In this review, we discuss the possibility of facilitating healthy aging through the regulation of networks through meditation. We propose that by practicing specific types of meditation, cognitive decline could be slowed, promoting a healthy lifestyle, which may enhance the quality of life for the elderly.


  • Open Access

    Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients

    by Carlo Lozano, Claudio Córdova, Ivanny Marchant, Rodrigo Zúñiga, Paola Ochova, Ricardo Ramírez-Barrantes, Wilfredo Alejandro González-Arriagada, Belén Rodríguez, Pablo Olivero

    Background: Breast cancer is a malignant disease that represents an important public health burden. The description of new molecular markers can be important to diagnosis, classification, and treatment. Transient receptor potential vanilloid 1 (TRPV1) polymodal channel is expressed in different neoplastic tissues and cell lines of breast cancer and associated with the regulation of tumor growth, tumor neurogenesis, cancer pain, and malignant progression of cancer. In primary and metastatic breast cancer tumors, TRPV1 is expressed during neoplastic transformation, invasive behavior, and resistance to cytotoxic therapy. Objective: The objective of this study was to describe the subcellular distribution of TRPV1 in invasive breast carcinomas and its association with survival. Methods: In 33 cases of invasive breast carcinomas, we identified immunohistochemical and immunofluorescent expression patterns of TRPV1 compared to healthy breast tissue. We characterized the expression of TRPV1 induced by estrogens in breast cancer cell lines MCF-7 and MDA to establish a model of the TRPV1–estrogen relationship regarding the malignant potential. We examined the association of TRPV1 patterns with patients’ survival with the Kaplan–Meyer model, using the log-rank test at 5 years of follow-up. The relation of TRPV1 expression patterns to the St. Gallen breast cancer subtypes was also tested. Results: Based on immunohistochemical expression pattern of TRPV1, we distinguished two main categories of breast cancer tissue, a “classical category” that exhibited diffuse expression of the channel and a “non-classical category” that expressed the channel in aggregates at the ER/Golgi and/or surrounding these structures. The classical pattern of TRPV1 was associated with a higher survival rate. In breast cancer cell lines, increasing doses of estrogens induced increased TRPV1 expression with nonclassical patterns at higher doses via a mechanism dependent on ER α. Conclusion: The expression and distribution of TRPV1 in invasive breast carcinomas may be considered as a biomarker for prognosis of the disease and a probable therapeutic target.


  • Open Access

    Proteostasis and Mitochondrial Role on Psychiatric and Neurodegenerative Disorders: Current Perspectives

    by Pablo Olivero, Carlo Lozano, Ramón Sotomayor-Zárate, Nicolás Meza-Concha, Marcelo Arancibia, Claudio Córdova, Wilfredo González-Arriagada, Ricardo Ramírez-Barrantes, Ivanny Marchant

    Proteostasis involves processes that are fundamental for neural viability. Thus, protein misfolding and the formation of toxic aggregates at neural level, secondary to dysregulation of the conservative mechanisms of proteostasis, are associated with several neuropsychiatric conditions. It has been observed that impaired mitochondrial function due to a dysregulated proteostasis control system, that is, ubiquitin-proteasome system and chaperones, could also have effects on neurodegenerative disorders. We aimed to critically analyze the available findings regarding the neurobiological implications of proteostasis on the development of neurodegenerative and psychiatric diseases, considering the mitochondrial role. Proteostasis alterations in the prefrontal cortex implicate proteome instability and accumulation of misfolded proteins. Altered mitochondrial dynamics, especially in proteostasis processes, could impede the normal compensatory mechanisms against cell damage. Thereby, altered mitochondrial functions on regulatory modulation of dendritic development, neuroinflammation, and respiratory function may underlie the development of some psychiatric conditions, such as schizophrenia, being influenced by a genetic background. It is expected that with the increasing evidence about proteostasis in neuropsychiatric disorders, new therapeutic alternatives will emerge.


  • Open Access

    Transient Receptor Potential Vanilloid 1 Expression Mediates Capsaicin-Induced Cell Death

    by Ricardo Ramírez-Barrantes, Claudio Córdova, Sebastian Gatica, Belén Rodriguez, Carlo Lozano, Ivanny Marchant, Cesar Echeverria, Felipe Simon, Pablo Olivero

    The transient receptor potential (TRP) ion channel family consists of a broad variety of non-selective cation channels that integrate environmental physicochemical signals for dynamic homeostatic control. Involved in a variety of cellular physiological processes, TRP channels are fundamental to the control of the cell life cycle. TRP channels from the vanilloid (TRPV) family have been directly implicated in cell death. TRPV1 is activated by pain-inducing stimuli, including inflammatory endovanilloids and pungent exovanilloids, such as capsaicin (CAP). TRPV1 activation by high doses of CAP (>10 μM) leads to necrosis, but also exhibits apoptotic characteristics. However, CAP dose–response studies are lacking in order to determine whether CAP-induced cell death occurs preferentially via necrosis or apoptosis. In addition, it is not known whether cytosolic Ca2+ and mitochondrial dysfunction participates in CAP-induced TRPV1-mediated cell death. By using TRPV1-transfected HeLa cells, we investigated the underlying mechanisms involved in CAP-induced TRPV1-mediated cell death, the dependence of CAP dose, and the participation of mitochondrial dysfunction and cytosolic Ca2+ increase. Together, our results contribute to elucidate the pathophysiological steps that follow after TRPV1 stimulation with CAP. Low concentrations of CAP (1 μM) induce cell death by a mechanism involving a TRPV1-mediated rapid and transient intracellular Ca2+ increase that stimulates plasma membrane depolarization, thereby compromising plasma membrane integrity and ultimately leading to cell death. Meanwhile, higher doses of CAP induce cell death via a TRPV1-independent mechanism, involving a slow and persistent intracellular Ca2+ increase that induces mitochondrial dysfunction, plasma membrane depolarization, plasma membrane loss of integrity, and ultimately, cell death.


  • Open Access

    TRPV1 may increase the effectiveness of estrogen therapy on neuroprotection and neuroregeneration

    by Pablo Olivero, Ricardo Ramírez-Barrantes, Ivanny Marchant

    Aging induces physical deterioration, loss of the blood brain barrier, neuronal loss-induced mental and neurodegenerative diseases. Hypotalamus-hypophysis-gonad axis aging precedes symptoms of menopause or andropause and is a major determinant of sensory and cognitive integrated function. Sexual steroids support important functions, exert pleiotropic effects in different sensory cells, promote regeneration, plasticity and health of the nervous system. Their diminution is associated with impaired cognitive and mental health and increased risk of neurodegenerative diseases. Then, restoring neuroendocrine axes during aging can be key to enhance brain health through neuroprotection and neuroregeneration, depending on the modulation of plasticity mechanisms. Estrogen-dependent transient receptor potential cation channel, subfamily V, member 1 (TRPV1) expression induces neuroprotection, neurogenesis and regeneration on damaged tissues. Agonists of TRPV1 can modulate neuroprotection and repair of sensitive neurons, while modulators as other cognitive enhancers may improve the survival rate, differentiation and integration of neural stem cell progenitors in functional neural network. Menopause constitutes a relevant clinical model of steroidal production decline associated with progressive cognitive and mental impairment, which allows exploring the effects of hormone therapy in health outcomes such as dysfunction of CNS. Simulating the administration of hormone therapy to virtual menopausal individuals allows assessing its hypothetical impact and sensitivity to conditions that modify the effectiveness and efficiency.


  • Open Access

    Perspectives of TRPV1 Function on the Neurogenesis and Neural Plasticity

    by R. Ramírez-Barrantes, C. Cordova, H. Poblete, P. Muñoz, I. Marchant, F. Wianny, P. Olivero

    The development of new strategies to renew and repair neuronal networks using neural plasticity induced by stem cell graft could enable new therapies to cure diseases that were considered lethal until now. In adequate microenvironment a neuronal progenitor must receive molecular signal of a specific cellular context to determine fate, differentiation, and location. TRPV1, a nonselective calcium channel, is expressed in neurogenic regions of the brain like the subgranular zone of the hippocampal dentate gyrus and the telencephalic subventricular zone, being valuable for neural differentiation and neural plasticity. Current data show that TRPV1 is involved in several neuronal functions as cytoskeleton dynamics, cell migration, survival, and regeneration of injured neurons, incorporating several stimuli in neurogenesis and network integration. The function of TRPV1 in the brain is under intensive investigation, due to multiple places where it has been detected and its sensitivity for different chemical and physical agonists, and a new role of TRPV1 in brain function is now emerging as a molecular tool for survival and control of neural stem cells.


  • Histochemical staining for intestinal dysganglionosis: over 30 years experience with more than 1,500 biopsies

    by Sandra Montedonico, Patricio Cáceres, Natalia Muñoz, Hugo Yáñez, Ricardo Ramírez, Bruno Fadda

    Intestinal dysganglionosis are a group of anomalies of the enteric nervous system that constitute infrequent but severe forms of constipation. Histochemical stainings are the gold standard diagnostic procedure for intestinal dysganglionosis. This study describes our experience with histochemistry in a large series of patients. Between 1977 and 2010, 1,589 biopsies from children with persistent chronic constipation were studied. The specimens were snap frozen, sectioned and stained with acetylcholinesterase (AChE), acetylcholinesterase counterstained with hematoxilin and succinic dehydrogenase (SDH) histochemical stainings. Among the 1,589 biopsies, 946 (59.5%) were rectal biopsies, 242 (15.2%) were internal sphincter biopsies, 346 (21.8%) were intestinal mapping studies and 42 (2.7%) of them were colon specimens from surgical resections. From the rectal biopsy group, 544 (57.5%) patients were reported as normal. Hirschsprung disease was found in 163 (17.2%) patients with a median age at diagnosis of 8 months and a male to female ratio of 3:1. Intestinal neuronal dysplasia was found in 162 (17.2%) patients, hypoganglionosis in 3 (0.3%) of them and ganglioneuromatosis in 1 (0.1%). In 73 (7.7%) patients, the biopsy was not conclusive for different reasons. 34 out of the 42 resected colon specimens were Hirschsprung disease. Intestinal neuronal dysplasia was found in the proximal segment of the aganglionic bowel in 15 out of 34 (44%) patients. All the aganglionic resected colon specimens had a previous aganglionic rectal biopsy. There were no false positive results in this group. Histochemical stainings continue to be the gold standard in the diagnosis of intestinal dysganglionosis. The combination of two histochemical staining techniques provides a high level of accuracy in the diagnosis of intestinal dysganglionosis.